reference/20768496

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20768496

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1469
issn	1468-2060 0003-4967
issueIdentifier	9
pageRange	1466-1469
publicationName	Annals of the Rheumatic Diseases
startingPage	1466
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6e60f992a18c1d86feae8b40b3ed48a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fc6b2ebfbea1710e5eebd4afbc04fa64
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6b7343adec4390fec175dfa5218b1449 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4b62845ed79f984741684bf1e3ee239d
bibliographicCitation	Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, Coates L, O'Connor PJ, Fraser A, Conaghan PG, Emery P. MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. Ann Rheum Dis. 2009 Sep;68(9):1466–9. doi: 10.1136/ard.2008.092213. PMID: 18952641.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b0c4352ce1ff36f5e2cdfa682e45a14 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b120e961293ad098c73ca43352ac651 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741d0eed67bc0c95f3d5da76b10fe29e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f39674204bfed30ccbde31f111f41967 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_053f3ac635a422d9ad701381dc0f02db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00aead3789a42bba83937f21bb68cda2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12029cc8de2a065cc76ce7f725b2c9cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7fa45b823a9028ae39a9b20541b492a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d534cf5eca4b3df271794f9fead5a910 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_172da0f0c2d44b6a67e5e7a3bcdd8b47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dcaa8decdf4efbf9dd7eb03faad2fbd
date	2008-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1136/ard.2008.092213 https://pubmed.ncbi.nlm.nih.gov/18952641
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640 https://portal.issn.org/resource/ISSN/1468-2060 https://portal.issn.org/resource/ISSN/0003-4967
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib
discusses	http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0446346 http://id.nlm.nih.gov/mesh/M0020791 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0382298 http://id.nlm.nih.gov/mesh/M0022150
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013167Q000188 http://id.nlm.nih.gov/mesh/D052246Q000627 http://id.nlm.nih.gov/mesh/D013450Q000627 http://id.nlm.nih.gov/mesh/D011725Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D014409Q000037 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D012446Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013167Q000473 http://id.nlm.nih.gov/mesh/D000077613 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D008159Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123619 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10712 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9287

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128620771

Total number of triples: 64.